Oregon News

Catch the 2025 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.

NEWS RELEASE: Providence Oregon and Aetna, a CVS Health company, have reached a multi-year agreement that brings Providence hospitals, clinics, and physicians across Oregon back in-network.

Providence Breast Care and Breast Surgery Clinics launch Prevention4ME, a groundbreaking program to empower women with personalized breast cancer risk assessments and proactive screening options.

Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.

New studies at Providence Cancer Institute offer hope to patients with limited treatment options.

Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.

Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.

A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.

Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.

In July 2025, Providence had the honor of celebrating the 150th anniversary of Providence St. Vincent, Oregon’s first hospital.

After careful consideration, we have made the difficult decision to close our inpatient obstetric and newborn care services at Providence Seaside Hospital.

Robotic thoracic surgery is less invasive, allowing patients to recover more quickly. A Providence Cancer Institute surgeon calls it a game-changer.

Update from Oregon Chief Executive Jennifer Burrows: Learn about the most recent financial sustainability measures for Oregon.

Hands-on experience in a laboratory at Providence Cancer Institute helps undergraduate students find their career path in biomedical fields.

Learn key facts about lung cancer at a free virtual talk hosted by Providence Cancer Institute and Asian Cancer Resource & Support Services.

A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.

A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.

Published in Nature NPJ Genomic Medicine, Providence-led Geno4ME research program study highlights early detection, personalized prevention and prospect of improved care outcomes.